Early Investigator Research Award – HT9425-PCRP-EIRA
- up to USD$300,000 over 2 years
- letters of intent due 3 August 2023
- 3 years or less postdoc research experience at 31 March 2024
- Supports research opportunities focused on prostate cancer for individuals in the early stages of their careers.
- applicants must have a designated mentor who is an experienced prostate cancer researcher.
- clinical trials not allowed
Exploration – Hypothesis Development Award – HT9425-PCRP-EHDA
- up to USD$100,000 over 2 years
- letters of intent due 22 June 2023
- Supports the exploration of highly innovative, untested, potentially groundbreaking concepts in prostate cancer.
- Emphasis is on innovation; the potential impact may be difficult to predict.
- Presentation of preliminary data is strongly discouraged.
- clinical trials not allowed
Idea Development Award – HT9425-PCRP-IDA
- up to USD$900,000 over 3 years
- letters of intent due 29 June 2023
- Supports new ideas that represent innovative, highrisk/high-gain approaches to prostate cancer research and have the potential to make an important contribution to one or more of the PCRP Overarching Challenges.
- emphasis on innovation and impact
- multi-disciplinary projects encouraged
- established and new investigator streams
- preliminary data encouraged but not required
- clinical trials not allowed
2023 PCRP Overarching Challenges
- Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer
- Develop new treatments or improve upon existing therapies to improve outcomes for men with lethal prostate cancer
- Advance health equity and reduce disparities in prostate cancer
- Define the biology of prostate cancer progression to lethal prostate cancer to reduce death
Supporting documents for download
